Patients with movement disorders Parkinson's disease,tremor, dystonia (G20-G26)
Conditions
Interventions
Group 1: As part of usual care: Implantation of deep brain stimulation device
Group 2: As part of usual care: No treatment with deep brain stimulation, because patients refuse this treatment.
Sponsors
Charité Universitätsmedizin Berlin / Klinik für Neurologie mit Experimenteller Neurologie Sektion Bewegungsstörungen und Neuromodulation
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: All patients are eligible for inclusion who: #1 Have been included in a corresponding study of a subproject of TR 295 and have consented to data transfer to the central clinical database as part of inclusion in the respective study. OR #2 Patients with movement disorders Parkinson's disease, tremor, dystonia (G20-G26: Extrapyramidal diseases and movement disorders) who are receiving DBS treatment as part of their therapy and who have consented to inclusion in the central clinical database. OR #3 Patient:s with movement disorders Parkinson's disease, tremor, dystonia (G20-G26: Extrapyramidal diseases and movement disorders) who are eligible for DBS treatment as part of their therapy but have not opted for DBS treatment and have consented to inclusion in the central clinical database (control group).
Exclusion criteria
Exclusion criteria: No signed informed consent form / inclusion criteria are not met
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life (EQ-5D-5L) Baseline = t0 / Follow-up = 12 months Occurrence of complications/adverse events | — |
Secondary
| Measure | Time frame |
|---|---|
| Not specified | — |
Countries
Germany
Contacts
Public ContactTRR 295 Coordinator
Charité – Universitätsmedizin Berlin
Outcome results
None listed